Search
Search Results
-
Correlation of Serum Lymphocyte-Derived Biomarkers in Muscle Invasive and Non-Muscle Invasive Bladder Cancer: a Hospital Based Retrospective Study
Serum lymphocyte-derived biomarkers substantially impact prognosis of bladder cancer. This study evaluated the preoperative serum lymphocyte-derived...
-
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
PurposeTo assess the prognostic value of sex for non-muscle-invasive/muscle-invasive bladder urothelial carcinoma (NMIBC/MIBC) treated with radical...
-
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
High-grade non-muscle-invasive bladder cancer (HG NMIBC) patients are at high risk (HR) of progression to muscle-invasion. Bladder-preserving...
-
Pathologic collision of urinary bladder urothelial carcinoma with small cell carcinoma: a case report
BackgroundUrothelial carcinoma is a major subtype of bladder cancer and small cell carcinoma (SCC) is a rare type of cancer in clinical practice....
-
Interobserver agreement for the Vesical Imaging-Reporting and Data System (VI-RADS) in differentiating non-muscle-invasive and muscle-invasive urinary bladder tumors
BackgroundBladder cancer is the most common tumor of the genitourinary tract. Transitional cell carcinoma is divided into two categories:...
-
Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study
AimIntravesical thermochemotherapy, also known as HIVEC (Hyperthermic Intra-VEsical Chemotherapy), represents an alternative adjuvant topical...
-
Efficacy and safety of tislelizumab plus bacillus-calmette guérin with or without chemotherapy as a bladder-sparing treatment for high-risk non-muscle-invasive bladder urothelial cancer: a real-world study
BackgroundDespite adequate transurethral resection of the bladder tumor (TURBT) followed by intravesical bacillus-calmette guérin (BCG), high-risk...
-
Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report
BackgroundUrothelial carcinoma arises from the inner urothelial membrane of the renal pelvis, ureter, and bladder and often causes macrohematuria....
-
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls
Bladder cancer (BC), predominantly comprising urothelial carcinomas (UCs), ranks as the tenth most common cancer worldwide. UCs with variant...
-
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report
BackgroundThe use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced...
-
Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma
ObjectiveTo investigate the diagnostic value of urine cyclic RNA-0071196 (circRNA-0071196) in the patients with bladder urothelial carcinoma (BUC).
...
-
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
BackgroundWith the advance in genome-wide analyses, genetic alternations have been found to play an important role in carcinogenesis and...
-
CT and MRI findings of small cell neuroendocrine carcinoma of the urinary bladder: comparison with urothelial carcinoma
ObjectiveThis study aimed to evaluate the efficacy of CT and MRI findings to differentiate small cell neuroendocrine carcinoma (SCNEC) from...
-
Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer
PurposeTo evaluate the association between preoperative pan-immune inflammation value (PIV) and overall survival (OS) and disease-free survival (DFS)...
-
Role of intravoxel incoherent motion MRI in diagnosis and assessment of invasiveness of urothelial bladder carcinoma
BackgroundUrinary bladder cancer is a common malignancy. Preoperative accurate judgment of the degree of tissue invasion is crucial to determine the...
-
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective
Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into the detrusor muscle layer. Transurethral resection of...
-
Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer
PurposeTo investigate computed tomography (CT)-based prediction model for identifying patients with high probability of non-muscle-invasive bladder...
-
Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma
The World Health Organization/International Society of Urological Pathology (2022 WHO/ISUP) classification categorizes noninvasive carcinomas based...
-
Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer
PurposeBladder cancer represents 3% of all new cancer diagnoses per year. We propose intravesical radionuclide therapy using the β-emitter 90 Y...
-
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
Purpose of ReviewThe treatment options for high-risk non-muscle invasive bladder cancer (NMIBC), particularly following BCG, remain limited. We...
